{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:36:59Z","timestamp":1768549019912,"version":"3.49.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Parkinson\u2019s disease is a complex, age-related, neurodegenerative disease associated with dopamine deficiency and both motor and nonmotor deficits. Therapeutic pathways remain challenging in Parkinson\u2019s disease due to the low accuracy of early diagnosis, the difficulty in monitoring disease progression, and the limited availability of treatment options.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Few data are present to identify urinary biomarkers for various ailments, potentially aiding in the diagnosis and tracking of illness progression in individuals with Parkinson\u2019s disease. Thus, the analysis of urinary metabolomic biomarkers (UMB) for early and mid-stage idiopathic Parkinson\u2019s disease (IPD) is the main goal of this systematic review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>For this study, six electronic databases were searched for articles published up to 23 February 2024: PubMed, Ovid Medline, Embase, Scopus, Science Direct, and Cochrane. 5,377 articles were found and 40 articles were screened as per the eligibility criteria. Out of these, 7 controlled studies were selected for this review. Genetic profiling for gene function and biomarker interactions between urinary biomarkers was conducted using the STRING and Cytoscape database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 40 metabolites were identified to be related to the early and mid-stage of the disease pathology out of which three metabolites, acetyl phenylalanine (a subtype of phenylalanine), tyrosine and kynurenine were common and most significant in three studies. These metabolites cause impaired dopamine synthesis along with mitochondrial disturbances and brain energy metabolic disturbances which are considered responsible for neurodegenerative disorders. Furoglycine, Cortisol, Hydroxyphenylacetic acid, Glycine, Tiglyglycine, Aminobutyric acid, Hydroxyprogesterone, Phenylacetylglutamine, and Dihydrocortisol were also found commonly dysregulated in two of the total 7 studies. 158 genes were found which are responsible for the occurrence of PD and metabolic regulation of the corresponding biomarkers from our study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The current review identified acetyl phenylalanine (a subtype of phenylalanine), tyrosine and kynurenine as potential urinary metabolomic biomarkers for diagnosing PD and identifying disease progression.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fbinf.2025.1513790","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T06:48:04Z","timestamp":1741589284000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Urinary based biomarkers identification and genetic profiling in Parkinson\u2019s disease: a systematic review of metabolomic studies"],"prefix":"10.3389","volume":"5","author":[{"given":"Neetu Rani","family":"Dhiman","sequence":"first","affiliation":[]},{"given":"Surbhi","family":"Singh","sequence":"additional","affiliation":[]},{"given":"Royana","family":"Singh","sequence":"additional","affiliation":[]},{"given":"Anand","family":"Kumar","sequence":"additional","affiliation":[]},{"given":"Varun Kumar","family":"Singh","sequence":"additional","affiliation":[]},{"given":"Abhishek","family":"Pathak","sequence":"additional","affiliation":[]},{"given":"Rameshwar Nath","family":"Chaurasia","sequence":"additional","affiliation":[]},{"given":"Vijay Nath","family":"Mishra","sequence":"additional","affiliation":[]},{"given":"Niraj Kumar","family":"Srivastava","sequence":"additional","affiliation":[]},{"given":"Swati","family":"Sahu","sequence":"additional","affiliation":[]},{"given":"Nikhil","family":"Pandey","sequence":"additional","affiliation":[]},{"given":"Deepika","family":"Joshi","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.31887\/dcns.2004.6.3\/galexander","article-title":"Biology of Parkinson\u2019s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder","volume":"6","author":"Alexander","year":"2004","journal-title":"Dialogues Clin. Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2018.02.022","article-title":"Serum metabolomics study in a group of Parkinson\u2019s disease patients from northern India","volume":"480","author":"Babu","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"B4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10072-020-04589-x","article-title":"Urinary kynurenine as a biomarker for Parkinson's disease","volume":"42","author":"Bai","year":"2021","journal-title":"Neurol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/brain\/awm304","article-title":"Metabolomic profiling to develop blood biomarkers for Parkinson's disease","volume":"131","author":"Bogdanov","year":"2008","journal-title":"Brain"},{"key":"B6","first-page":"859","article-title":"Plasma and urinary HPLC-ED determination of the ratio of 8-OHdG\/2-dG in Parkinson\u2019s disease","volume":"57","author":"Bolner","year":"2011","journal-title":"Clin. Lab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e73076","DOI":"10.1371\/journal.pone.0073076","article-title":"The human urine metabolome","volume":"8","author":"Bouatra","year":"2013","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1600-0404.1998.tb00614.x","article-title":"Cortisol is higher in parkinsonism and associated with gait deficit","volume":"97","author":"Charlett","year":"1998","journal-title":"Acta Neurol. Scand."},{"key":"B9","doi-asserted-by":"publisher","first-page":"101514","DOI":"10.1016\/j.arr.2021.101514","article-title":"Identification of blood-based biomarkers for diagnosis and prognosis of Parkinson's disease: a systematic review of proteomics studies","volume":"73","author":"Chelliah","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2225800","DOI":"10.1080\/14756366.2023.2225800","article-title":"Research progress on the kynurenine pathway in the prevention and treatment of Parkinson's disease","volume":"38","author":"Chen","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.omtn.2023.04.030","article-title":"GraphCPIs: a novel graph-based computational model for potential compound-protein interactions","volume":"32","author":"Chen","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3390\/ph16101495","article-title":"Profiling analysis of tryptophan metabolites in the urine of patients with Parkinson\u2019s disease using LC MS\/MS","volume":"16","author":"Chung","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B15","doi-asserted-by":"publisher","first-page":"bbae650","DOI":"10.1093\/bib\/bbae650","article-title":"Heterogeneous graph contrastive learning with gradient balance for drug repositioning","volume":"26","author":"Cui","year":"2025","journal-title":"Briefings Bioinforma."},{"key":"B16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/s1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"De Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1136\/jnnp.2011.245746","article-title":"Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour","volume":"82","author":"Djamshidian","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrneurol.2009.135","article-title":"Biological fluid biomarkers in neurodegenerative parkinsonism","volume":"5","author":"Eller","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1134\/S1819712421020057","article-title":"Significance of oxidative damage to proteins and DNA in the blood of patients with parkinson\u2019s Disease in Assessing the Severity of the Disease","volume":"15","author":"Fedorova","year":"2021","journal-title":"Neurochem. J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s0197-4580(97)80309-0","article-title":"Twenty-four hour cortisol release profiles in patients with Alzheimer\u2019s and Parkinson\u2019s disease compared to normal controls: ultradian secretory pulsatility and diurnal variation","volume":"18","author":"Hartmann","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"B20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/jnnp-2014-309676","article-title":"Identification of novel biomarkers for Parkinson's disease by metabolomic technologies","volume":"87","author":"Hatano","year":"2016","journal-title":"J. Neurology, Neurosurg. & Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurology, Neurosurg. & Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e20795","DOI":"10.1371\/journal.pone.0020795","article-title":"Association between urinary excretion of cortisol and markers of oxidatively damaged DNA and RNA in humans","volume":"6","author":"Joergensen","year":"2011","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/978-1-4612-5312-9_46","article-title":"Hydroxyphenylacetic acid concentration in the CSF of patients with neurological and psychiatric disorders","volume-title":"Neurobiology of the trace amines","author":"Kobayashi","year":"1984"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10072-019-04143-4","article-title":"Quantitative metabolomics of saliva using proton NMR spec-troscopy in patients with Parkinson\u2019s disease and healthy controls","volume":"41","author":"Kumari","year":"","journal-title":"Neurol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"104670","DOI":"10.1016\/j.neuint.2020.104670","article-title":"Metabolomic analysis of serum using proton NMR in 6-OHDA experimental PD model and patients with PD","volume":"134","author":"Kumari","year":"","journal-title":"Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cca.2020.08.005","article-title":"Identification of potential urine biomarkers in idiopathic Parkinson's disease using NMR","volume":"510","author":"Kumari","year":"","journal-title":"Clin. Chim. Acta"},{"key":"B29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1021\/pr500807t","article-title":"LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease","volume":"14","author":"Luan","year":"","journal-title":"J. Proteome Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.parkreldis.2015.09.009","article-title":"Elevated excretion of biopyrrin as a new marker for idiopathic Parkinson's disease","volume":"21","author":"Luan","year":"","journal-title":"Park. Relat. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"13888","DOI":"10.1038\/srep13888","article-title":"Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease","volume":"5","author":"Luan","year":"","journal-title":"Sci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0022-510x(97)00119-6","article-title":"Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson\u2019s disease","volume":"151","author":"Mally","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0022-510x(97)00069-5","article-title":"Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson\u2019s disease","volume":"150","author":"Molina","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"B34","volume-title":"Study quality assessment tools. U.S. Department of health and human services","year":"2013"},{"key":"B35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","article-title":"Cytoscape Automation: empowering workflow-based network analysis","volume":"20","author":"Otasek","year":"2019","journal-title":"Genome Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021"},{"key":"B37","doi-asserted-by":"publisher","first-page":"D833","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants","volume":"45","author":"Pi\u00f1ero","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3686-z","article-title":"Dopamine precursors depletion impairs impulse control in healthy volunteers","author":"Ramdani","year":"2015","journal-title":"Psychopharmacology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/s1474-4422(05)70079-x","article-title":"Prevalence of Parkinson\u2019s disease in China","volume":"4","author":"Rocca","year":"2005","journal-title":"Lancet Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1126\/science.166.3911.1417","article-title":"m-Hydroxyphenylacetic acid formation from L-dopa in man: suppression by neomycin","volume":"166","author":"Sandler","year":"1969","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1341950","DOI":"10.3389\/fmolb.2024.1341950","article-title":"Metabolomic profiling reveals altered phenylalanine metabolism in Parkinson's disease in an Egyptian cohort","volume":"11","author":"Shebl","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.bbabio.2016.03.012","article-title":"Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis","volume":"1857","author":"Tretter","year":"2016","journal-title":"Biophys. Acta - Bioenerg."},{"key":"B44","doi-asserted-by":"publisher","first-page":"605887","DOI":"10.3389\/fnins.2021.605887","article-title":"Monoamine levels and Parkinson\u2019s disease progression: evidence from a high-performance Liquid Chromatography study","volume":"15","author":"Wichit","year":"2021","journal-title":"Front. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1016\/j.csbj.2024.06.032","article-title":"A heterogeneous information network learning model with neighborhood-level structural representation for predicting lncRNA-miRNA interactions","volume":"23","author":"Zhao","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"121360","DOI":"10.1016\/j.ins.2024.121360","article-title":"Regulation-aware graph learning for drug repositioning over heterogeneous biological network","volume":"686","author":"Zhao","year":"2025","journal-title":"Inf. Sci."}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1513790\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T06:48:07Z","timestamp":1741589287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1513790\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":43,"alternative-id":["10.3389\/fbinf.2025.1513790"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2025.1513790","relation":{},"ISSN":["2673-7647"],"issn-type":[{"value":"2673-7647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"article-number":"1513790"}}